Tag: Novartis
Novartis India’s NEST 2.0 spotlights emerging talent shaping the future of...
Participants competed for a prize pool of INR 7,50,000 lakhs and stand a chance to secure pre-placement interviews with the Novartis Development Hub in India
1 in 4 Indians at cardiovascular risk from elevated lipoprotein(a), warn...
New survey across Asia Pacific and Middle East shows 66% skip routine heart checks and nearly half are unaware of the genetic link to heart disease
Pharma’s next decade will be shaped by cross-industry partnerships & workforce...
Novartis MD further reflected on the growing importance of public health campaigns. Drawing parallels with past AIDS and HIV awareness initiatives
Next-Gen innovators Win Big at NEST, paving the way for healthcare...
The four winning teams, recognized for their ingenuity, technical excellence, and real-world impact, were awarded from Rs 8,00,000 prize pool and secured pre-placement interview opportunities with Novartis Development hub in India
BioAsia 2023: 5 stories by Dr Vas Narasimhan that provide source...
Dr. Vas Narasimhan, CEO, Novartis, Switzerland in in keynote address shared five stories he hopes will provide a source of inspiration to continue to find medicines for the world
Decoding the future of PharmaTech & Patient Data Protection
Leaders from Microsoft, Novartis and Roche Group deliberate on the collaboration of pharma and technology
Novartis India extends access to its medicines in India by signing...
The arrangement brings together the manufacturing and development synergies of Novartis India Limited with the sales and distribution strengths of Dr. Reddy’s Laboratories
Novartis renews WHO medicine donation pledge with aim of ending leprosy
Novartis leprosy medicine donation program with WHO extended to 2025. Program has already treated over 7 million patients since 2000..........................
Novartis’s 5 year long clinical study on type 2 diabetes treatment...
Early combination treatment strategy with vildagliptin and metformin was superior to the standard of care in newly diagnosed type 2 diabetes patients. The landmark VERIFY study is the first to investigate the long-term clinical benefits of this early combination strategy in type 2 diabetes...................
Alcon debuts as independent, publicly traded company
After the company completed its separation from Novartis, it has begun trading on SIX Swiss Exchange and New York Stock Exchange...............